单、双胎妊娠并发子痫前期临床分析

目的探讨单、双胎妊娠并发子痫前期的临床特点及妊娠结局。 方法选取2009年1月至2013年4月在广州医科大学附属第三医院产科住院分娩的43例双胎并发子痫前期的孕妇为研究组,362例单胎并发子痫前期产妇作为对照组,回顾性分析两组患者的临床特点及母婴结局的情况。 结果研究组住院时间(13.28±11.23)d,较对照组(9.48±4.97)d延长,t＝2.20,P<0.05。研究组剖宫产率、胎膜早破、产后出血、心力衰竭的发生率分别为97.67%、13.95%、11.63%、11.63%,明显高于对照组(79.83%、5.25%、5.25%和4.14%),差异有统计学意义(P<0.05)。研究组发生新生儿感染和黄疸分别为25.58%和48.84%,高于对照组15.19%和32.60%,差异有统计学意义(P<0.05)。 结论双胎并发子痫前期与单胎并发子痫前期相比,会增加孕产妇的剖宫产、胎膜早破、产后出血、心力衰竭等发生率,同时延长产妇的住院时间。     

不同病因妊娠合并重度肺动脉高压临床分析

目的:探讨不同病因妊娠合并重度肺动脉高压(PAH)围产期的监护及妊娠终止时机和方式。方法:收集2014年1月至2019年12月于广州医科大学第三附属医院ICU收治的妊娠合并重度PAH患者28例的临床资料,分析其病因、临床特点及妊娠结局。结果:(1)28例妊娠合并重度PAH患者中,病因为先天性心脏病占最大比率10例(35.7%),其次是风湿性心瓣膜病7例(25.0%),特发性肺动脉高压(IPAH)居第3位6例(21.4%),肺栓塞2例(7.1%),子痫前期2例(7.1%),系统性红斑狼疮相关性PAH 1例(3.6%)。(2)先天性心脏病、风湿性心瓣膜病、子痫前期、系统性红斑狼疮相关性PAH的孕妇预后良好,无一例死亡;6例IPAH患者中3例好转,3例死亡,病死率高达50.0%,均为病情极其危重由外院急诊转入本院,未进行规律的产前检查,并在产后并发了大出血;2例肺栓塞患者,1例预后良好,1例死亡,为在外院顺产后因重度心力衰竭转入本院,呼吸循环衰竭死亡。(3)共计26例围产儿(均为早产儿),其中存活围产儿22例,死胎4例;医源性流产儿2例。先天性心脏病孕妇的存活围产儿占87.5%(7/8),IPAH孕妇的存活围产儿占83.3%(5/6),而新生儿窒息发生率高达80.0%(4/5),且新生儿出生平均体质量较低为1656±552 g。结论:不同病因妊娠合并重度PAH的母婴结局不同,未规律行产前检查的IPAH患者预后较差,病死率最高,母婴结局最差,而先天性心脏病孕妇及围产儿的预后相对较好。规范化、全程、多学科的孕产妇管理是降低重度PAH孕产妇病死率的有效方法,是改善母婴结局的关键。【     

不同亚型子痫前期患者母儿结局分析

目的分析不同亚型子痫前期患者的母儿结局。 方法回顾性分析2009年1月1日至2019年12月31日在广州医科大学附属第三医院分娩的2960例单胎子痫前期患者早产组与足月产组、早发型组与晚发型组的临床资料及母儿结局。 结果(1)母亲结局：①早产组与足月产组剖宫产率分别为(80.85% vs 61.67%, χ²＝1.327)、入住重症监护病房率(11.84% vs 2.25%, χ²＝86.844)，P值均<0.05；②早发型与晚发型剖宫产率分别为(77.61% vs 70.30%, χ²＝1.327，P<0.05)、入住重症监护病房率(13.00% vs 4.55%, χ²＝69.158，P<0.05)。(2)新生儿结局：①早产组与足月产组在新生儿出生平均体重[(1472.19±673.50)g与(3067.49±523.92)g，Z＝-42.4]，活产比例(81.35% vs 99.31%, χ²＝2.204)，新生儿窒息率(6.39% vs 0.79%, χ²＝53.51)P均<0.05。②早发型组与晚发型组新生儿出生体重[(1169.53±482.39)g vs(2765.37±683.22)g，Z＝-43.895]，活产比例(74.64% vs 98.31%, χ²＝3.926)，新生儿窒息率(8.71% vs 1.31%, χ²＝86.82)，差异均有统计学意义(P<0.05)。 结论子痫前期患者早产组与足月产组相比，早产组母体及新生儿结局均较差。早发型与晚发型子痫前期相比，早发型母儿结局均较差。     

早发型和晚发型重度子痫前期分娩方式及母婴结局分析

目的探讨早发型和晚发型重度子痫前期分娩方式及母婴结局。方法收集1977-2010年在西安交通大学医学院第一附属医院产科住院的重度子痫前期患者4457例,其中早发型860例,晚发型3597例。回顾性分析其分娩方式及母婴结局。结果早发型和晚发型重度子痫前期剖宫产率分别为57.7%和36.9%,早发型明显高于晚发型(P=0.02);胎盘早剥是最常见并发症,在早发型和晚发型重度子痫前期发生率分别为6.7%和4.6%(P<0.05)。早发型和晚发型重度子痫前期围生儿死亡率分别为3.6%和2.2%(P<0.01)。特别是早发型妊娠34周前终止妊娠者,围生儿死亡率高达4.9%。结论子痫前期终止妊娠的主要方式为剖宫产术;发病孕周越早,母婴不良结局发生率越高。     

早发型重度子痫前期早产婴儿存活影响因素分析

目的探讨早发型重度子痫前期早产儿婴儿期存活的影响因素。方法对比分析2001年1月至2006年5月在北京大学第三医院分娩的孕周〈34周的早发型重度子痫前期活产早产儿与随机抽取的同时期孕周匹配的自发性早产活产早产儿婴儿期结局,并进行多因素分析。结果研究组活产新生儿86例,随访71例（82.6%）;对照组活产新生儿114例,随访96例（84.2%）。研究组婴儿期死亡15例（21.1%）,其中早期新生儿期死亡12例（16.9%）;对照组婴儿期死亡10例（10.4%）,早期新生儿期死亡5例（5.2%）。研究组早期新生儿期死亡率明显高于对照组（P=0.014）,两组间婴儿期死亡率差异无统计学意义（P〉0.05）。多因素分析显示,是否入住NICU实施积极救治是影响早产儿婴儿期死亡率的主要因素（OR 0.016,95%CI 0.002-0.113）。当去除NICU因素,孕龄和有无新生儿窒息是影响早发型重度子痫前期早产儿婴儿期死亡率的主要因素（OR 0.516,95%CI 0.296-0.902;OR 5.363,95%CI 1.703-16.891）。结论早发型重度子痫前期是早产儿早期新生儿期死亡的影响因素,孕龄和新生儿窒息是影响早发型重度子痫前期婴儿期生存率的主要因素。家属救治态度以及NICU在改善高危儿预后方面有重要影响。重度子痫前期作为独立因素不增加34孕周前早产儿的婴儿期不良结局风险,对早发型重度子痫前期患者进行保守治疗可以改善婴儿预后,降低婴儿丢失率,家属救治意愿是不可忽视的因素。     

重度子痫前期并发急性肾损伤临床分析

目的了解重度子痫前期并发急性肾损伤(acute kidney injury,AKI)患者的临床发病特点。 方法对广州医科大学附属第三医院产科2005年8月至2011年7月收治的90例重度子痫前期并发AKI的病例资料进行回顾性分析,包括患者的一般资料、发病特点和临床结局等。 结果(1)重度子痫前期并发AKI的主要病因依次为严重产后出血、胎盘早剥、HELLP综合征以及合并基础肾脏疾病;(2)多器官功能障碍的发生率为63.3%(57/90),重症监护病房入住率64.4%(58/90),病死率15.6%(14/90);(3)AKI 1期治愈率71.9%(23/32),2期治愈率62.5%(5/8),3期治愈率28.0%(14/50),即随着急性肾损伤分期的增加,重度子痫前期并发AKI患者的治愈率逐渐下降,而病死率有所增加;(4)重度子痫前期合并AKI死亡的14例患者中,主要死因分别为多器官功能障碍7例,脑血管意外4例,严重产后出血2例,呼吸衰竭1例。 结论重度子痫前期并发AKI的主要病因为严重产后出血、胎盘早剥、HELLP综合征以及合并基础肾脏疾病;并发多器官功能障碍、脑血管意外和严重产后出血是患者死亡的主要原因。     

重度子痫前期孕妇的分娩时机与新生儿结局

重度子痫前期及子痫是妊娠期特发性疾病,是妊娠期严重威胁母儿健康的严重并发症.早发型重度子痫前期更易导致母婴严重并发症,因新生儿不成熟及低体重所致的患病率及病死率极高.目前,终止妊娠是治疗重度子痫前期惟一有效的方法,何时终止妊娠对母婴结局最有利是研究的热点.     

重度子痫前期孕妇的分娩时机与新生儿结局

重度子痫前期及子痫是妊娠期特发性疾病,是妊娠期严重威胁母儿健康的严重并发症.早发型重度子痫前期更易导致母婴严重并发症,因新生儿不成熟及低体重所致的患病率及病死率极高.目前,终止妊娠是治疗重度子痫前期惟一有效的方法,何时终止妊娠对母婴结局最有利是研究的热点.     

重度子痫前期孕妇的分娩时机与新生儿结局

重度子痫前期及子痫是妊娠期特发性疾病,是妊娠期严重威胁母儿健康的严重并发症.早发型重度子痫前期更易导致母婴严重并发症,因新生儿不成熟及低体重所致的患病率及病死率极高.目前,终止妊娠是治疗重度子痫前期惟一有效的方法,何时终止妊娠对母婴结局最有利是研究的热点.     

早发型重度子痫前期及保守治疗对早产儿预后影响因素分析

目的 探讨早发型重度子痫前期以及保守治疗对早产儿预后的影响.方法 对2001年1月至2006年5月于北京大学第三医院产科分娩、孕周<34周的早发型重度子痫前期患者76例(研究组)活产早产儿及同期孕周匹配的自发性早产患者84例(对照组)活产儿进行生长发育评估.研究组活产早产儿86例,随访71例(82.6%);对照组活产新生儿114例,随访96例(84.2%).应用丹佛智能发育筛查表(DDST)进行智能发育筛查.观察指标包括:DDST测评结果,妊娠期及围生期病历资料和临床指标.结果 研究组早产儿存活56例,存活儿智能发育正常43例(77%),可疑12例(21%),无法解释1例(2%),未发现智能发育异常或脑瘫患儿.对照组早产儿存活86例,存活儿智能发育正常65例(76%),可疑14例(16%),异常5例(6%,均为脑瘫患儿),无法解释2例(2%).早发型重度子痫前期早产儿与自发性早产早产儿比较智能发育差异无统计学意义(P>0.05).多因素分析显示,胎龄和新生儿窒息是影响早发型重度子痫前期婴儿期生存率的主要因素;出生体重是影响智能发育的保护性因素(OR0.278,95% CI 0.087～0.891).结论 在早期早产中,重度子痫前期影响小儿存活率,但不是影响小儿智能发育的因素;出生体重是早产儿智能发育的保护性因素.早发型重度子痫前期行长时间保守治疗对智能发育无不良影响;经严格选择病例,进行保守治疗延迟分娩,可以最大程度改善胎儿成熟度,改善预后.     

Pregnancy and liver transplantation

To define the risks and outcomes associated with pregnancy and liver transplantation, we reviewed our experience in managing eight pregnant women who had undergone orthotopic liver transplantation. Seven patients conceived after transplantation; the interval from transplantation to conception ranged from 3 weeks to 24 months. One patient received an allograft at 26 weeks' gestation for hepatic failure secondary to acute fulminant hepatitis B. Of the seven patients who conceived after transplantation, six had live births and one electively terminated her pregnancy. Five patients developed worsening hypertension and/or preeclampsia. Three patients developed severe preeclampsia and required delivery. One patient suffered acute allograft rejection during pregnancy which was successfully treated with corticosteroids. Two patients had persistent elevation of serum transaminases and two had severe anemia. The mean gestational age at delivery was 32.8 weeks. Of the six live births to women who conceived after transplantation, five infants survived and are well and one infant died. There were no congenital anomalies. All mothers are alive at this time. Pregnancy in recipients of hepatic allografts is associated with good perinatal outcome, but there is an increased risk of preeclampsia, worsening hypertension, and preterm delivery. Pregnancy does not appear to have a deleterious effect on hepatic graft function or survival. Joint management of these patients by a transplant specialist and a perinatologist is essential.     

子痫前期并发胎儿生长受限的临床特征及妊娠结局分析

目的 探讨子痫前期并发胎儿生长受限(fetal growth restriction,FGR)的临床特征及母儿结局.方法 回顾性分析2009年1月1日至2019年12月31日在广州医科大学附属第三医院产科就诊并分娩的单胎子痫前期患者的病例资料,根据是否合并FGR,分为FGR组和对照组,分析两组的临床特征及母儿结局.结果...     

早发型与晚发型子痫前期的临床特点及母儿结局分析

目的 分析早发型与晚发型子痫前期的临床特征及母儿结局.方法 收集2015年1月至2020年12月6年间在广州医科大学附属第三医院分娩的诊断为子痫前期的单胎孕产妇2693例的临床资料,采用回顾性研究方法分析早发型(873例)与晚发型子痫前期孕妇(1820例)的临床特征及母儿结局.结果 早发型和晚发型子痫前期患者孕次比较[...     

早发型重度子痫前期的临床特点及围生期结局

目的探讨早发型重度子痫前期患者的临床特点及对母婴预后的影响。方法选取2001年1月～2004年12月天津市中心妇产科医院住院的794例重度子痫前期患者作为研究对象，将病例分为早发型重度子痫前期（妊娠〈32周，312例）和晚发型重度子痫前期（妊娠≥32周，482例）。回顾性分析比较两组患者的临床资料。结果早发型重度子痫前期组临床严重并发症如子痫、心衰、肺水肿、腹水、胸腔积液、胎盘早剥、产后出血的发生率均明显高于晚发型重度子痫前期组，差异有显著性（P〈0．01）；早发型重度子痫前期组围产儿死亡率及新生儿Apgar评分≤7分的发生率显著高于晚发型重度子痫前期组（P〈0．01）。结论早发型重度子痫前期病情严重，围产儿预后不良，应根据母婴情况，严格选择病例进行期待疗法，同时密切监测母婴病情变化。     

Severe preeclampsia at <25 weeks of gestation: maternal and neonatal outcomes

OBJECTIVE: The purpose of this study was to determine maternal and neonatal outcomes of women who were delivered because of severe preeclampsia before 25 weeks of gestation. STUDY DESIGN: We used a computerized database to identify 3800 women with preeclampsia among 35,937 deliveries from 1991 to 1997. Of these, 39 women (1%) with severe preeclampsia were delivered before 25 weeks of gestation. We abstracted outcomes in these women and their newborns. RESULTS: All 39 women had severe preeclampsia as defined by clinical and/or laboratory criteria. Thirty-three of the 39 women had severe-range hypertension. Twenty-one women (54%) experienced morbidity that included abruptio placentae (n = 5), HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome (n = 9), renal insufficiency (n = 5), and eclampsia (n = 3). No women required dialysis or intensive care unit admission, and none of the women died. All maternal morbidities reversed after delivery. Twenty-two infants (55%) were live-born. Only 4 infants (10%) survived, all with severe handicaps. CONCLUSION: In women with severe preeclampsia before 25 weeks of gestation, delivery is associated with minimal short-term maternal morbidities, although neonatal morbidity and death are appreciable.     

Criteria of pregnancy termination in women with preeclampsia

Preeclampsia remains an important cause of maternal and neonatal mortality and morbidity. Delivery is always the appropriate therapy for the mother but may be responsible for neonatal adverse outcomes, particularly when it occurs at less than < 34 weeks' gestation. In women with severe preeclampsia at < 34 weeks expectant management to improve neonatal mortality and morbidity may be performed under close monitoring of both the mother and the fetus. Any severe condition of the mother (HELLP syndrome, abruptio placentae, eclampsia) or the fetus (abnormal fetal heart rate) should lead to prompt delivery. In women with mild preeclampsia, expectant management should be performed until 38 weeks gestation.     

Mild gestational hypertension remote from term: progression and outcome

OBJECTIVE: Limited information is available regarding the progression of disease in women with mild gestational hypertension. Our purpose was to describe the prognostic signs in the natural course of mild gestational hypertension and pregnancy outcomes in women who were remote from term with mild gestational hypertension that was expectantly managed. STUDY DESIGN: Women with mild gestational hypertension participating in an outpatient hypertension monitoring program were studied. Inclusion criteria were patients with a singleton pregnancy between 24 and 35 weeks' gestation who had no proteinuria by dipstick (0 or trace) on the first 2 days of program participation. Progression to preeclampsia was the primary outcome. The rate of progression to severe preeclampsia, obstetric complications, and neonatal outcomes were secondary measures. Data were compared by independent Student t and Fisher exact tests where applicable. RESULTS: A total of 748 patients were studied during the observation period; preeclampsia (persistent proteinuria > or = 1+) developed in 343 (46%), and 72 (9.6%) had antepartum progression to severe preeclampsia. No significant differences in maternal age, race, marital status, or tobacco use were observed between those women in whom persistent proteinuria developed and those in whom it did not develop. Gestational age of the infants at delivery (36.5 +/- 2.4 vs 37.4 +/- 2.0 weeks), birth weight (2752 +/- 767 vs 3038 +/- 715 g), incidence of small-for-gestational-age newborns (24.8% vs 13.8%), and duration of neonatal hospital stay (7.1 +/- 10 vs 5.0 +/- 9.3 days) differed significantly in the patients with versus those without proteinuria (P <.001 for all). CONCLUSIONS: In patients with mild gestational hypertension remote from term, 46% ultimately had preeclampsia, with progression to severe disease in 9.6%. The development of proteinuria is associated with an earlier gestational age at delivery, lower birth weight, and an increased incidence of small-for-gestational age newborns.